因素 | 癫痫组 (n = 49) | 无癫痫组 (n = 1229) | Z/c2值 | P值 |
性别[例(%)] |
|
| 0.022 | 0.881 |
男 | 34 (69.4%) | 865 (70.4%) |
|
|
女 | 15 (30.6%) | 364 (29.6%) |
|
|
年龄[分M (Q1, Q3)] | 55.32 ± 5.90 | 55.26 ± 7.73 | 0.170 | 0.865 |
既往史[例(%)] |
|
|
|
|
高血压 | 32 (65.3%) | 870 (70.8%) | 0.682 | 0.409 |
糖尿病 | 16 (32.7%) | 416 (33.8%) | 0.030 | 0.862 |
房颤 | 5 (10.2%) | 51 (4.1%) | 4.122 | 0.042 |
恶性肿瘤 | 4 (8.2%) | 34 (2.8%) | 4.757 | 0.029 |
脑梗死 | 6 (12.2%) | 150 (12.2%) | 0.000 | 0.993 |
吸烟史[例(%)] | 21 (42.9%) | 516 (42%) | 0.015 | 0.903 |
饮酒史[例(%)] | 16 (32.7%) | 426 (34.7%) | 0.084 | 0.772 |
TOAST分型[例(%)] |
|
| 17.276 | 0.004 |
LAA | 31 (63.3%) | 661 (53.8%) |
|
|
CS | 6 (12.2%) | 47 (3.8%) |
|
|
SAA | 6 (12.2%) | 361 (29.4%) |
|
|
SOE | 4 (8.2%) | 51 (4.1%) |
|
|
SUE | 1 (2%) | 89 (7.2%) |
|
|
NIHSS评分[分M (Q1, Q3)] | 5 (2, 7.5) | 2 (1, 4) | 4.856 | <0.001 |
静脉溶栓[例(%)] | 2 (4.1%) | 95 (7.7%) | 0.894 | 0.344 |
他汀[例(%)] | 48 (98%) | 121 (98.6%) | 0.147 | 0.702 |
降压类药物[例(%)] | 23 (46.9%) | 545 (44.3%) | 0.128 | 0.720 |
抗生素类药物[例(%)] | 12 (24.5%) | 49 (4.0%) | 43.580 | <0.001 |
皮层受累[例(%)] | 36 (73.5%) | 95 (24%) | 60.130 | <0.001 |
多脑叶受累[例(%)] | 33 (67.3%) | 265 (21.6%) | 58.304 | <0.001 |
MCA供血区[例(%)] | 41 (83.7%) | 616 (50.1%) | 12.714 | <0.001 |
出血转化[例(%)] | 6 (12.2%) | 33 (2.7%) | 14.556 | <0.001 |
ES [例(%)] | 10 (20.4%) | 8 (0.6%) | 141.324 | <0.001 |